Wilms' tumor protein 1 (WT1) peptide vaccination in AML patients: Predominant TCR CDR3β sequence associated with remission in one patient is detectable in other vaccinated patients

Cancer Immunology, Immunotherapy

Volumn 61, Issue 3, 2012, Pages 313-322

  Ochsenreither, Sebastian ^a   Fusi, Alberto ^a   Geikowski, Anne ^a   Stather, David ^a   Busse, Antonia ^a   Stroux, Andrea ^a   Letsch, Anne ^a   Keilholz, Ulrich ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acute myeloid leukemia; Peptide vaccination; T cell receptor bias; Wilms' tumor protein 1

Indexed keywords

EPITOPE; GAMMA INTERFERON; HLA A2 ANTIGEN; PEPTIDE VACCINE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; WILM TUMOR PROTEIN 1[126-134] VACCINE; CANCER VACCINE; HLA A*02:01 ANTIGEN; HLA-A*02:01 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE FRAGMENT; SUBUNIT VACCINE; WT1 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BONE MARROW; CELLULAR IMMUNITY; CLINICAL ARTICLE; COMPLEMENTARY DETERMINING REGION 3BETA; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA REMISSION; MALE; MOLECULAR CLONING; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ACUTE DISEASE; CELL CLONE; CHEMISTRY; COMPLEMENTARITY DETERMINING REGION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; MYELOID LEUKEMIA; REMISSION; T LYMPHOCYTE; VACCINATION;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; CANCER VACCINES; CLONE CELLS; COMPLEMENTARITY DETERMINING REGIONS; EPITOPES; FEMALE; HLA-A2 ANTIGEN; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REMISSION INDUCTION; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, SUBUNIT; WT1 PROTEINS; YOUNG ADULT;

EID: 84860798495     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-1099-y     Document Type: Article

References (49)

1. Rezvani K, Yong AS, Mielke S, Savani BN, Musse L, Superata J, Jafarpour B, Boss C, Barrett AJ (2008) Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies. Blood 111(1):236-242. doi:10.1182/blood-2007-08-108241
2. Keilholz U, Letsch A, Busse A, Asemissen AM, Bauer S, Blau IW, Hofmann WK, Uharek L, Thiel E, Scheibenbogen C (2009) A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS. Blood 113(26):6541-6548. doi:10.1182/blood-2009-02-202598
3. Oka Y, Tsuboi A, Murakami M, Hirai M, Tominaga N, Nakajima H, Elisseeva OA, Masuda T, Nakano A, Kawakami M, Oji Y, Ikegame K, Hosen N, Udaka K, Yasukawa M, Ogawa H, Kawase I, Sugiyama H (2003) Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis. Int J Hematol 78(1):56-61 (Pubitemid 36899903)
4. Scheibenbogen C, Letsch A, Thiel E, Schmittel A, Mailaender V, Baerwolf S, Nagorsen D, Keilholz U (2002) CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia. Blood 100(6):2132-2137. doi:10.1182/blood-2002-01-0163 (Pubitemid 35001248)
5. Ho WY, Nguyen HN, Wolfl M, Kuball J, Greenberg PD (2006) In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naive repertoire. J Immunol Methods 310(1-2):40-52. doi:10.1016/j.jim.2005.11.023 (Pubitemid 43375974)
6. Wolfl M, Kuball J, Ho WY, Nguyen H, Manley TJ, Bleakley M, Greenberg PD (2007) Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. Blood 110(1):201-210. doi: 10.1182/blood-2006-11-056168 (Pubitemid 47026836)
7. Argaet VP, Schmidt CW, Burrows SR, Silins SL, Kurilla MG, Doolan DL, Suhrbier A, Moss DJ, Kieff E, Sculley TB, Misko IS (1994) Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. J Exp Med 180(6):2335-2340 (Pubitemid 24351615)
8. Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, Friese M, Schroder R, Deckert M, Schmidt S, Ravid R, Rajewsky K (2000) Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 192(3):393-404 (Pubitemid 30629164)
9. Pantaleo G, Demarest JF, Soudeyns H, Graziosi C, Denis F, Adelsberger JW, Borrow P, Saag MS, Shaw GM, Sekaly RP et al (1994) Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature 370(6489):463-467. doi:10.1038/370463a0 (Pubitemid 24263551)
10. Moss PA, Moots RJ, Rosenberg WM, Rowland-Jones SJ, Bodmer HC, McMichael AJ, Bell JI (1991) Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc Natl Acad Sci USA 88(20):8987-8990
11. Lehner PJ, Wang EC, Moss PA, Williams S, Platt K, Friedman SM, Bell JI, Borysiewicz LK (1995) Human HLA-A0201- restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J Exp Med 181(1):79-91
12. Callan MF, Annels N, Steven N, Tan L, Wilson J, McMichael AJ, Rickinson AB (1998) T cell selection during the evolution of CD8+ T cell memory in vivo. Eur J Immunol 28(12):4382-4390. doi:10.1002/(SICI)1521-4141(199812)28: 12<4382:AID-IMMU4382>3.0.CO;2-Z (Pubitemid 28558669)
13. Hong J, Zang YC, Tejada-Simon MV, Kozovska M, Li S, Singh RA, Yang D, Rivera VM, Killian JK, Zhang JZ (1999) A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis. J Immunol 163(6):3530-3538. doi:ji-v163n6p3530
14. Burrows SR, Silins SL, Moss DJ, Khanna R, Misko IS, Argaet VP (1995) T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J Exp Med 182(6):1703-1715
15. Lim A, Trautmann L, Peyrat MA, Couedel C, Davodeau F, Romagne F, Kourilsky P, Bonneville M (2000) Frequent contribution of T cell clonotypes with public TCR features to the chronic response against a dominant EBV-derived epitope: application to direct detection of their molecular imprint on the human peripheral T cell repertoire. J Immunol 165(4): 2001-2011. doi:ji-v165n4p2001
16. Kuwana M, Medsger TA Jr, Wright TM (1997) Highly restricted TCR-alpha beta usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope. J Immunol 158(1):485-491 (Pubitemid 127483892)
17. Tynan FE, Burrows SR, Buckle AM, Clements CS, Borg NA, Miles JJ, Beddoe T, Whisstock JC, Wilce MC, Silins SL, Burrows JM, Kjer-Nielsen L, Kostenko L, Purcell AW, McCluskey J, Rossjohn J (2005) T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. Nat Immunol 6(11):1114-1122. doi:10.1038/ni1257 (Pubitemid 41541789)
18. Kjer-Nielsen L, Clements CS, Brooks AG, Purcell AW, Fontes MR, McCluskey J, Rossjohn J (2002) The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization. J Immunol 169(9):5153-5160 (Pubitemid 35217185)
19. Turner SJ, Kedzierska K, Komodromou H, La Gruta NL, Dunstone MA, Webb AI, Webby R, Walden H, Xie W, McCluskey J, Purcell AW, Rossjohn J, Doherty PC (2005) Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations. Nat Immunol 6(4):382-389. doi:10.1038/ni1175 (Pubitemid 41716778)
20. Kedzierska K, Day EB, Pi J, Heard SB, Doherty PC, Turner SJ, Perlman S (2006) Quantification of repertoire diversity of influenza-specific epitopes with predominant public or private TCR usage. J Immunol 177(10):6705-6712. doi:177/10/6705
21. Kedl RM, Rees WA, Hildeman DA, Schaefer B, Mitchell T, Kappler J, Marrack P (2000) T cells compete for access to antigen-bearing antigen-presenting cells. J Exp Med 192(8):1105-1113
22. Turner SJ, Doherty PC, McCluskey J, Rossjohn J (2006) Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol 6(12):883-894. doi:10.1038/nri1977 (Pubitemid 44851731)
23. Cole DJ, Wilson MC, Rivoltini L, Custer M, Nishimura MI (1997) T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes. Cancer Res 57(23):5320-5327 (Pubitemid 27516370)
24. Dietrich PY, Walker PR, Quiquerez AL, Perrin G, Dutoit V, Lienard D, Guillaume P, Cerottini JC, Romero P, Valmori D (2001) Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptide with diverse and nonoverlapping T-cell receptor repertoires. Cancer Res 61(5):2047-2054 (Pubitemid 32692026)
25. Pittet MJ, Gati A, Le Gal FA, Bioley G, Guillaume P, de Smedt M, Plum J, Speiser DE, Cerottini JC, Dietrich PY, Romero P, Zippelius A (2006) Ex vivo characterization of allo-MHCrestricted T cells specific for a single MHC-peptide complex. J Immunol 176(4):2330-2336. doi:176/4/2330
26. Sensi M, Traversari C, Radrizzani M, Salvi S, Maccalli C, Mortarini R, Rivoltini L, Farina C, Nicolini G, Wolfel T et al (1995) Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan- A/MART-1. Proc Natl Acad Sci USA 92(12):5674-5678
27. Trautmann L, Labarriere N, Jotereau F, Karanikas V, Gervois N, Connerotte T, Coulie P, Bonneville M (2002) Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens. Eur J Immunol 32(11): 3181-3190. doi:10.1002/1521-4141(200211)32:11<3181: AIDIMMU3181> 3.0.CO;2-2
28. Derre L, Bruyninx M, Baumgaertner P, Ferber M, Schmid D, Leimgruber A, Zoete V, Romero P, Michielin O, Speiser DE, Rufer N (2008) Distinct sets of alphabeta TCRs confer similar recognition of tumor antigen NY-ESO-1157-165 by interacting with its central Met/Trp residues. Proc Natl Acad Sci USA 105(39):15010-15015. doi:10.1073/pnas.0807954105
29. Ochsenreither S, Fusi A, Busse A, Bauer S, Scheibenbogen C, Stather D, Thiel E, Keilholz U, Letsch A (2011) "Wilms Tumor Protein 1" (WT1) peptide vaccination-induced complete remission in a patient with acute myeloid leukemia is accompanied by the emergence of a predominant T-cell clone both in blood and bone marrow. J Immunother 34(1):85-91. doi:10.1097/CJI. 0b013e3181f3cc5c
30. Giudicelli V, Chaume D, Lefranc MP (2005) IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. Nucleic Acids Res 33 (Database issue):D256-D261. doi:10.1093/nar/gki010 (Pubitemid 40207873)
31. Ochsenreither S, Fusi A, Busse A, Letsch A, Haase D, Thiel E, Scheibenbogen C, Keilholz U (2009) Long term presence of a single predominant tyrosinase-specific T-cell clone associated with disease control in a patient with metastatic melanoma. Int J Cancer. doi:10.1002/ijc.24939
32. Keilholz U, Golding-Lang P, Bechrakis NE, Max N, Letsch A, Schmittel A, Scheibenbogen C, Heufelder K, Egermont A, Thiel E (2004) Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction. Clin Cancer Res 10:1605-1612 (Pubitemid 38435549)
33. Ochsenreither S, Fusi A, Busse A, Nagorsen D, Schrama D, Becker J, Thiel E, Keilholz U (2008) Relative quantification of TCR Vbeta-chain families by real time PCR for identification of clonal T-cell populations. J Transl Med 6:34. doi:10.1186/1479-5876-6-34
34. Brochet X, Lefranc MP, Giudicelli V (2008) IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 36 (Web Server issue):W503-W508. doi:10.1093/nar/gkn316
35. Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4(4):406-425
36. Lefranc MP, Giudicelli V, Ginestoux C, Jabado-Michaloud J, Folch G, Bellahcene F, Wu Y, Gemrot E, Brochet X, Lane J, Regnier L, Ehrenmann F, Lefranc G, Duroux P (2009) IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res 37 (Database issue):D1006-D1012. doi:10.1093/nar/gkn838
37. Trautmann L, Rimbert M, Echasserieau K, Saulquin X, Neveu B, Dechanet J, Cerundolo V, Bonneville M (2005) Selection of T cell clones expressing high-affinity public TCRs within human cytomegalovirus-specific CD8 T cell responses. J Immunol 175(9):6123-6132. doi:175/9/6123
38. Vignard V, Lemercier B, Lim A, Pandolfino MC, Guilloux Y, Khammari A, Rabu C, Echasserieau K, Lang F, Gougeon ML, Dreno B, Jotereau F, Labarriere N (2005) Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan- A-specific T cells. J Immunol 175(7):4797-4805. doi:175/7/4797
39. Yokosuka T, Takase K, Suzuki M, Nakagawa Y, Taki S, Takahashi H, Fujisawa T, Arase H, Saito T (2002) Predominant role of T cell receptor (TCR)-alpha chain in forming preimmune TCR repertoire revealed by clonal TCR reconstitution system. J Exp Med 195(8):991-1001 (Pubitemid 34412001)
40. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P (1999) A direct estimate of the human alphabeta T cell receptor diversity. Science 286(5441):958-961. doi:7939
41. Campregher PV, Srivastava SK, Deeg HJ, Robins HS, Warren EH (2010) Abnormalities of the alphabeta T-cell receptor repertoire in advanced myelodysplastic syndrome. Exp Hematol 38(3):202-212. doi:10.1016/j.exphem.2009. 12.004
42. Sloand EM, Melenhorst JJ, Tucker ZC, Pfannes L, Brenchley JM, Yong A, Visconte V, Wu C, Gostick E, Scheinberg P, Olnes MJ, Douek DC, Price DA, Barrett AJ, Young NS (2011) T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy. Blood 117(9): 2691-2699. doi:10.1182/blood-2010-04-277921
43. Serana F, Sottini A, Caimi L, Palermo B, Natali PG, Nistico P, Imberti L (2009) Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients. J Transl Med 7:21. doi:10.1186/1479-5876-7-21
44. Venturi V, Price DA, Douek DC, Davenport MP (2008) The molecular basis for public T-cell responses? Nat Rev Immunol 8(3):231-238. doi:10.1038/nri2260 (Pubitemid 351323289)
45. Venturi V, Kedzierska K, Price DA, Doherty PC, Douek DC, Turner SJ, Davenport MP (2006) Sharing of T cell receptors in antigen-specific responses is driven by convergent recombination. Proc Natl Acad Sci USA 103(49):18691-18696. doi:10.1073/pnas.0608907103 (Pubitemid 44913472)
46. Robins HS, Campregher PV, Srivastava SK, Wacher A, Turtle CJ, Kahsai O, Riddell SR, Warren EH, Carlson CS (2009) Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood 114(19):4099-4107. doi:10.1182/blood-2009-04-217604
47. Yoshinaga SK, Whoriskey JS, Khare SD, Sarmiento U, Guo J, Horan T, Shih G, Zhang M, Coccia MA, Kohno T, Tafuri-Bladt A, Brankow D, Campbell P, Chang D, Chiu L, Dai T, Duncan G, Elliott GS, Hui A, McCabe SM, Scully S, Shahinian A, Shaklee CL, Van G, Mak TW, Senaldi G (1999) T-cell co-stimulation through B7RP-1 and ICOS. Nature 402(6763):827-832. doi: 10.1038/45582 (Pubitemid 129638129)
48. de Souza AP, Bonorino C (2009) Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses. Expert Rev Anticancer Ther 9(9):1317-1332. doi:10.1586/era.09.88
49. Gaur U, Aggarwal BB (2003) Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 66(8):1403-1408. doi:S0006295203004908